Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Biorxiv : the Preprint Server for Biology|April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progressionSilvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Scientific Data|August 8, 2024
Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkersJessica M Logan, Carmela Martini, Alexandra Sorvina, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Oncogene|September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancerSumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
Cancer & Metabolism|January 16, 2022
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnoverNikki L Raftopulos, Tinashe C Washaya, Andreas Niederprüm, et al.
Molecular Cancer Research : MCR|January 17, 2019
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate CancerSeher Balaban, Zeyad D Nassar, Alison Y Zhang, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
Pageof 19